Your browser doesn't support javascript.
loading
Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.
Sandri, Silvana; Watanabe, Luis R M; Oliveira, Erica Aparecida de; Faião-Flores, Fernanda; Migliorini, Silene; Tiago, Manoela; Felipe-Silva, Aloisio; Vazquez, Vinícius de Lima; da Costa Souza, Paola; Consolaro, Márcia Edilaine Lopes; Campa, Ana; Maria-Engler, Silvya Stuchi.
Afiliação
  • Sandri S; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
  • Watanabe LRM; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
  • Oliveira EA; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
  • Faião-Flores F; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
  • Migliorini S; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
  • Tiago M; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
  • Felipe-Silva A; Department of Pathology, Faculdade de Medicina (FMUSP), Universidade de São Paulo, São Paulo, Brazil.
  • Vazquez VL; Institute of Research and Education and Melanoma/Sarcoma Surgery, Barretos Cancer Hospital, Barretos, SP, Brazil.
  • da Costa Souza P; Laboratório Souza de Patologia, Maringá, Paraná, Brazil.
  • Consolaro MEL; Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Paraná, Brazil.
  • Campa A; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
  • Maria-Engler SS; Skin Biology Group, Department of Clinical Chemistry and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil. Electronic address: silvya@usp.br.
Pharmacol Res ; 159: 104998, 2020 09.
Article em En | MEDLINE | ID: mdl-32535222
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Indolamina-Pirrol 2,3,-Dioxigenase / Vemurafenib / Melanoma / Antineoplásicos Limite: Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Indolamina-Pirrol 2,3,-Dioxigenase / Vemurafenib / Melanoma / Antineoplásicos Limite: Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda